NSEGeneral Updates5 Aug 2026 · 5 Aug 2026, 07:54 pm
General Updates
Aster DM Quality Care Limited · ASTERDM
✦ AI SummaryM&A
Aster DM Quality Care Limited has informed the Exchange about the outcome of Board Meeting held on 5 August, 2026, where they approved the Notice of 18th AGM and Postal Ballot, termination of operations and management agreement in respect of Aster G. Madegowda Hospital, Maddur, and acquisition of equity shares of United CIIGMA Institute of Medical Sciences.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
ASTERDM: Aster DM Quality Care Limited has informed the Exchange about the outcome of Board Meeting held on 5 August, 2026-Others- Approval of Notice of 18th AGM and Postal Ballot and other required disclosures.
Attachments (1)
📄pdf
Download →
ASTERDM2_05082026195303_BM_Outcome-sd.pdf
View document text
05 August 2026
BSE Limited The National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex,
Dalal Street, Mumbai 400001, Bandra (East), Mumbai 400051,
Maharashtra, India Maharashtra, India
Scrip Code: 540975 Scrip Symbol: ASTERDM
Dear Sir / Madam,
Subject: Outcome of Board Meeting held on 05 August 2026
i. Approval of Notice of Postal Ballot and Notice of 18th Annual General Meeting
ii. Termination of the operations and management agreement in respect of Aster G.
Madegowda Hospital, Maddur
iii. Acquisition of equity shares of United CIIGMA Institute of Medical Sciences, an existing
subsidiary company of the Company
Ref: Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
(“Listing Regulations”)
With reference to our letter dated 30 July 2026 and in accordance with Regulation 30 of the Listing
Regulations, we wish to inform you that the Board of Directors of Aster DM Quality Care Limited
(formerly known as Aster DM Healthcare Limited) (“the Board” and “the Company”, respectively) at
its meeting held today i.e. 5 August 2026, inter alia, has approved:
1. Seeking approval of shareholders for special business through Postal Ballot and Notice of Postal
Ballot. The Notice of Postal Ballot will be sent to the shareholders and stock exchanges in due
course.
2. Convening 18th Annual General Meeting of the Company on Monday, 28 September 2026, at 11:30
A.M. IST through video conferencing or other audio-video means and the notice thereof. The
Notice of 18th Annual General Meeting will be sent to the shareholders and stock exchanges in
due course.
3. Termination of the operations and management agreement in respect of Aster G. Madegowda
Hospital, Maddur.
4. Acquisition of equity shares of United CIIGMA Institute of Medical Sciences, an existing subsidiary
company of the Company, pursuant to the exercise of put option rights by certain minority
shareholders under the Shareholders' Agreement.
The relevant details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI
Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are
provided as Annexure I and II respectively.
Aster DM Q uality Care Limited
(Formerly Aste r DM Healthcare Ltd.)
Registered Office: No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev CIN: L85110TS2008PLC207383
Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Telephone: +91 96060 61833
E-mail: cs@asterqualitycare.com
Corporate Office: Brigade Deccan Heights 20th & 12th Floor, Website: www.asterqualitycare.com
#42, 5th Mile, Tumkur Rd, Yeshwanthpur Industrial Area, Phase 1,
Yeshwanthpur, Bengaluru-560022
The Meeting of the Board of Directors commenced at 02:30 PM (IST) and concluded at 04:40 PM (IST).
The above information will also be hosted on the website of the Company i.e.
www.asterqualitycare.com
Kindly take the above on records.
Thank you,
Yours faithfully,
For Aster DM Quality Care Limited
(Formerly Aster DM Healthcare Limited)
Hemish Purushottam
Company Secretary and Compliance Officer
M. No: A24331
Aster DM Q uality Care Limited
(Formerly Aste r DM Healthcare Ltd.)
Registered Office: No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev CIN: L85110TS2008PLC207383
Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Telephone: +91 96060 61833
E-mail: cs@asterqualitycare.com
Corporate Office: Brigade Deccan Heights 20th & 12th Floor, Website: www.asterqualitycare.com
#42, 5th Mile, Tumkur Rd, Yeshwanthpur Industrial Area, Phase 1,
Yeshwanthpur, Bengaluru-560022
Annexure I
Details as required under Regulation 30 of the SEBI Listing Regulations read along with SEBI Master
Circular
S. No Particulars Details
1 date of such binding agreement, if 1 April 2023
any, entered for sale of such
unit/division, if any
2 amount & percentage of turnover 0.15% of the revenue for the entity during the last
or revenue or income and net f inancial year
worth of the listed entity
contributed by such unit or
division during the last financial
year;
3 date of closure or estimated time 5 August 2026
of closure; (or such effective date as may be finalized between
the parties)
4 reasons for closure The hospital has not achieved the anticipated
operational scale and profitability and has incurred
sustained operating losses since commencement of
operations. Accordingly, following a strategic review,
the Company has decided to discontinue the
arrangement and exit the facility.
Aster DM Q uality Care Limited
(Formerly Aste r DM Healthcare Ltd.)
Registered Office: No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev CIN: L85110TS2008PLC207383
Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Telephone: +91 96060 61833
E-mail: cs@asterqualitycare.com
Corporate Office: Brigade Deccan Heights 20th & 12th Floor, Website: www.asterqualitycare.com
#42, 5th Mile, Tumkur Rd, Yeshwanthpur Industrial Area, Phase 1,
Yeshwanthpur, Bengaluru-560022
Annexure II
Details as required under Regulation 30 of the SEBI Listing Regulations read along with SEBI
Master Circular
S. No Particulars Details
1 Name of the target entity, details in brief Name: United CIIGMA Institute of Medical
such as size, turnover etc. Sciences Private Limited (“UCIMSPL”)
Date of incorporation: 7 February 2011
Authorized Share Capital: Rs. 52,00,00,000/-
(Rupees Fifty-Two Crore Only) comprising
5,20,00,000 equity shares of face value of Rs. 10/-
each.
Paid-up Share Capital: Rs. 51,36,67,110/- (Rupees
Fifty-one crore thirty-six lakhs sixty-seven
thousand one hundred and ten Only) comprising
5,13,66,711 equity shares of face value of Rs.10/-
each.
Turnover:
For the financial year ended 31 March 2026:
Rs 153.64 crores.
2 Whether the acquisition would fall
within related party transaction(s) and
whether the promoter/ promoter
The transaction is done at an arm’s length basis.
group/ group companies have any
interest in the entity being acquired? If
yes, nature of interest and details
thereof and whether the same is done
at “arm’s length”
Aster DM Quality Care Limited
(Formerly Aster DM Healthcare Ltd.)
Registered Office: No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev CIN: L85110TS2008PLC207383
Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Telephone: +91 96060 61833
E-mail: cs@asterqualitycare.com
Corporate Office: Brigade Deccan Heights 20th & 12th Floor, Website: www.asterqualitycare.com
#42, 5th Mile, Tumkur Rd, Yeshwanthpur Industrial Area, Phase 1,
Yeshwanthpur, Bengaluru-560022
S. No Particulars Details
3 Industry to which the entity being Healthcare Industry
acquired belongs
4 Objects and impact of acquisition Acquisition of up to an additional 12% equity stake in
(including but not limited to, disclosure of United CIIGMA Institute of Medical Sciences Private
reasons for acquisition of target entity, if Limited (UCIMSPL) through exercise of the put option
its business is outside the main line of by the Promoter/Promoter Group of UCIMSPL, in
business of the listed entity) accordance with the Shareholders' Agreement dated
June 10, 2022. UCIMSPL will continue to be the
Acquirer’s Subsidiary.
5 Brief details of any governmental or Not Applicable
regulatory approvals required for the
acquisition;
6 Indicative time period for completion of Within the next 1–2 months
the acquisition;
7 Consideration - whether cash Cash consideration
consideration or share swap or any
other form and details of the same;
8 Cost of acquisition and/or the price at Up to Rs. 40.93 crores
which the shares are acquired;
9 Percentage of shareholding / control Up to 12%
acquired and / or number of shares
acquired;
10 Brief background about the entity
UCIMSPL is headquartered in Chhatrapati
acquired in terms of products/line of
Sambhajinagar and was incorporated on 7 February
business acquired, date of incorporation,
2011.
history of last 3 years turnover, country in
which the acquired entity has presence
and any other significant information (in
The company is primarily engaged
[Showing first 8,000 characters — download PDF for full document]